Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion, a Netherlands-based venture capital firm specializing in life sciences investment across Europe. The SPAC completed its initial public offering in 2021 with a focus on identifying targets in the European life sciences and biotechnology sector, leveraging Forbion's deep domain expertise and established network within the region's healthcare ecosystem. The company filed a Form 10-Q with the SEC on October 30, 2023, indicating it remained an active reporting entity at that time. Visit SpacDesk and sign up for full data, filings history, and real-time status tracking on FRBN and hundreds of other SPACs.